Medicare billing address
CMS Medicare provider billing file
925 Deis DrFairfield, OH 45014
CMS public data · NPI 1649216326
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Douglas E Feeney, MD
Specialty
Credential
MD
NPI
1649216326
Primary source state
OH
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Douglas E Feeney, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
925 Deis DrCMS Doctors & Clinicians file
10220 Alliance RdCMS Doctors & Clinicians file
2000 Joseph E Sanker BlvdCMS Doctors & Clinicians file
4360 Ferguson DrIn the 2024 CMS provider billing file, this NPI had 631 Medicare beneficiaries and 14,493 total services. The average beneficiary age was 76, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$747,376.31
Total Medicare payment amount
$585,927.24
Medicare beneficiaries
631
Total services
14,493
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
34%
CMS beneficiary-panel share
Ischemic heart disease
34%
CMS beneficiary-panel share
Chronic kidney disease
29%
CMS beneficiary-panel share
Atrial fibrillation
23%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, degarelix, 1 mg | 4,080 | $4.20 |
| Leuprolide injectable, camcevi, 1 mg | 3,780 | $56.99 |
| Urinalysis, manual test | 679 | $3.39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 644 | $16.52 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 504 | $127.42 |
| Insertion of needle into vein for collection of blood sample | 425 | $8.63 |
| Psa (prostate specific antigen) measurement, total | 369 | $17.97 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 233 | $90.17 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 139 | $34.30 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 135 | $178.33 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1649216326. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Tamsulosin Hcl | Tamsulosin Hcl | 1,038 | 2,588.3 | $13,002.34 |
| 2 | Abiraterone Acetate | Abiraterone Acetate | 622 | 663 | $1,347,206.94 |
| 3 | Finasteride | Finasteride | 588 | 1,611.9 | $6,478.53 |
| 4 | Prednisone | Prednisone | 567 | 686.3 | $2,143.35 |
| 5 | Alendronate Sodium | Alendronate Sodium | 146 | 340.8 | $1,120.27 |
| 6 | Solifenacin Succinate | Solifenacin Succinate | 134 | 238.7 | $2,524.03 |
| 7 | Erleada | Apalutamide | 112 | 112 | $1,328,232.85 |
| 8 | Orgovyx | Relugolix | 100 | 100 | $260,788.47 |
| 9 | Potassium Chloride | Potassium Chloride | 86 | 147.1 | $983.06 |
| 10 | Alfuzosin Hcl Er | Alfuzosin Hcl | 84 | 190 | $1,224.78 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Chicago, Pritzker School Of Medicine
Graduation year
1990
Group/practice field
Tri State Urologic Services Psc Inc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.